PCM
ELV icon

Prelude Capital Management’s Elevance Health ELV Stock Holding History

Prelude Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-25,000
Closed -$6.57M – 1862
2018
Q4 		$6.57M Hold
25,000
– – 0.44% 33
2018
Q3 		$6.85M Hold
25,000
– – 0.4% 39
2018
Q2 		$5.95M Buy
+25,000
New +$5.79M 0.38% 45

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Prelude Capital Management's ELV Position: Q2 2026 in Review

Prelude Capital Management increased its Elevance Health (ELV) stake by 115% in Q2 2026, buying an estimated $756K and bringing the position to 3,809 shares worth $1.47M. The position accounts for 0.11% of the portfolio, ranked #228.

Prelude Capital Management first reported a position in ELV in Q4 2013 and has held it in 28 quarters since. The position peaked at $1.8M in Q2 2022. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Prelude Capital Management held 3,809 shares of Elevance Health worth $1.47M as of Q2 2026.
  • Prelude Capital Management bought 2,039 Elevance Health shares in Q2 2026, an estimated $756K.
  • Elevance Health made up 0.11% of Prelude Capital Management's portfolio in Q2 2026, its #228 holding.
  • Prelude Capital Management first reported a position in Elevance Health in Q4 2013 and has held it in 28 quarters since.
  • Prelude Capital Management's Elevance Health position peaked at $1.8M in Q2 2022.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.